<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Generic Erosion on FinanClub</title>
    <link>https://finan.club/tags/generic-erosion/</link>
    <description>Recent content in Generic Erosion on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sun, 06 Aug 2023 12:13:03 +0000</lastBuildDate><atom:link href="https://finan.club/tags/generic-erosion/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>1273 BMY</title>
      <link>https://finan.club/us/bmy/</link>
      <pubDate>Sun, 06 Aug 2023 12:13:03 +0000</pubDate>
      
      <guid>https://finan.club/us/bmy/</guid>
      <description>score:1273
Chances: Institutions&amp;rsquo; substantial holdings in Bristol-Myers Squibb imply significant influence on the stock. Merck&amp;rsquo;s stronger-than-expected second-quarter earnings may signal positive prospects for the pharmaceutical sector. Bristol-Myers Squibb&amp;rsquo;s earnings and revenue surprises for Q2 2023 could provide insights into the stock&amp;rsquo;s future performance.</description>
    </item>
    
  </channel>
</rss>
